- Home
- PTMN vs KOD Comparison
PTMN vs KOD Comparison
Compare PTMN & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTMN
- KOD
- Stock Information
- Founded
- PTMN 2006
- KOD 2009
- Country
- PTMN United States
- KOD United States
- Employees
- PTMN N/A
- KOD N/A
- Industry
- PTMN Finance: Consumer Services
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PTMN Finance
- KOD Health Care
- Exchange
- PTMN Nasdaq
- KOD Nasdaq
- Market Cap
- PTMN 156.9M
- KOD 186.3M
- IPO Year
- PTMN N/A
- KOD 2018
- Fundamental
- Price
- PTMN $16.39
- KOD $9.87
- Analyst Decision
- PTMN Hold
- KOD Hold
- Analyst Count
- PTMN 3
- KOD 4
- Target Price
- PTMN $19.33
- KOD $8.00
- AVG Volume (30 Days)
- PTMN 62.1K
- KOD 489.6K
- Earning Date
- PTMN 11-07-2024
- KOD 11-14-2024
- Dividend Yield
- PTMN 16.84%
- KOD N/A
- EPS Growth
- PTMN N/A
- KOD N/A
- EPS
- PTMN 0.39
- KOD N/A
- Revenue
- PTMN $65,828,000.00
- KOD N/A
- Revenue This Year
- PTMN N/A
- KOD N/A
- Revenue Next Year
- PTMN N/A
- KOD N/A
- P/E Ratio
- PTMN $42.48
- KOD N/A
- Revenue Growth
- PTMN N/A
- KOD N/A
- 52 Week Low
- PTMN $16.12
- KOD $2.19
- 52 Week High
- PTMN $20.84
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- PTMN 31.74
- KOD 72.01
- Support Level
- PTMN $16.21
- KOD $8.33
- Resistance Level
- PTMN $16.55
- KOD $9.55
- Average True Range (ATR)
- PTMN 0.24
- KOD 0.93
- MACD
- PTMN 0.02
- KOD -0.02
- Stochastic Oscillator
- PTMN 31.71
- KOD 61.73
About PTMN Portman Ridge Finance Corporation
Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.